Oncolytics Biotech has obtained new method of use patents for its cancer immunotherapy drug pelareorep in multiple countries, with U.S. patent issuance expected soon. The company is expanding its intellectual property portfolio to include composition of matter patents for a next-generation pelareorep, aiming to extend patent protection into the late 2040s. These patents protect both the drug’s therapeutic applications and manufacturing processes, supporting Oncolytics’ long-term development and commercial plans. The company is also pursuing accelerated patent examination in the U.S. to gain earlier clarity on protection scope, which could aid clinical and partnership decisions.
Oncolytics Biotech's patent portfolio update provides context for readers. For those tracking the health sector, as of Oct 13, 2026 03:02 WIB, 66 of 128 US health stocks on Pluang rose while 61 fell. Among notable movers, Bruker Corporation (BRKR) dropped 4.78% to USD 56.03 with a typical hold time of 4 days, MiniMed Group (MMED) declined 4.36% to USD 18.85, and Definium Therapeutics (DFTX) also fell 4.36% to USD 35.29 but saw 100% buy order activity and a shorter typical hold time of 2 days.
Bureau Veritas disclosed its share buyback transactions conducted between October 5 and October 9, 2026. This activity reflects the company's ongoing efforts to manage its capital structure and potentially enhance shareholder value. Investors should ...
In Q3 2026, TRON DAO reported a milestone of $2.21 trillion in stablecoin settlements, with the network surpassing $30 trillion in cumulative transaction volume. The active user base grew by nearly 10%, and stablecoin supply increased to $93.88 billi...
Bureau Veritas disclosed its treasury shares transactions conducted between October 5 and October 9, 2026. This update is part of the company's regular reporting obligations to inform investors about changes in its treasury shares holdings. Such disc...
Pepeto, a new Ethereum-based cryptocurrency, has launched its page on CoinMarketCap, indicating a Binance listing is near. The project features a working bridge across Ethereum, BNB Chain, and Solana, with zero-cost token transfers and AI contract ch...
Crédit Agricole has signed an agreement to acquire 100% of IKB Deutsche Industriebank, a key financier for Germany's Mittelstand companies. This acquisition strengthens Crédit Agricole's expansion in Germany, Europe's largest economy, aligning with i...
